Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Marksans Pharma: Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company (Both Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter Ended 30Th June 2023
News Announcement

Marksans Pharma: Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company (Both Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter Ended 30Th June 2023

02-Aug-2023 Follow Value Research Online on Google download pdfDownload PDF Marksans Pharma

MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) along with Limited Review Report thereon for the Quarter ended 30th June 2023

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds